There's no doubt that there will be plenty of choices. The drug is known to work on over 100 different types of cancer. I think the point is to isolate the cancers that exhibit the strongest reaction to Coramsine and pursue those through phase II. This will give the best chance of a positive (and potentially dramatic) outcome.
- Forums
- ASX - By Stock
- SBP
- genentech up $11 billion
SBP
solbec pharmaceuticals limited
genentech up $11 billion, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost